|
The "Genetrails AML/MDS Gene Mutation Panel" results monitor any mutations that might show. I had three mutations before transplant (SF3B1, KRAS, IKZF1). The KRAS mutation is a common site for an activating mutation in leukemias. None have appeared since the transplant. Additionally, I regularly have "Cytogenetics Bone Marrow Chromosome Analysis" and "Hematopathology" tests at the same time. Several other tests are routinly done following SCT. There are about three pages of information for each of these tests.
__________________
age 70, dx RAEB-2 on 11-26-2013 w/11% blasts. 8 cycles Vidaza 3w/Revlimid. SCT 8/15/2014, relapsed@Day+210 (AML). Now(SCT-Day+1005). Prepping w/ 10 days Dacogen for DLI on 6/9/2017.
Last edited by bailie : Sun Mar 5, 2017 at 01:02 PM.
|